Clover Health Investments | 10-Q: FY2025 Q2 Revenue Beats Estimate at USD 477.62 M

LB filings
2025.08.08 12:14
portai
I'm PortAI, I can summarize articles.

Revenue: As of FY2025 Q2, the actual value is USD 477.62 M, beating the estimate of USD 468.3 M.

EPS: As of FY2025 Q2, the actual value is USD -0.02.

Insurance Segment Financial Metrics

Premiums Earned, Net

  • Three Months Ended June 30, 2025: $469.8 million
  • Three Months Ended June 30, 2024: $349.9 million
  • Six Months Ended June 30, 2025: $926.7 million
  • Six Months Ended June 30, 2024: $691.6 million

Net Medical Claims Incurred

  • Three Months Ended June 30, 2025: $378.0 million
  • Three Months Ended June 30, 2024: $248.3 million
  • Six Months Ended June 30, 2025: $731.4 million
  • Six Months Ended June 30, 2024: $513.5 million

Salaries and Benefits

  • Three Months Ended June 30, 2025: $61.3 million
  • Three Months Ended June 30, 2024: $55.5 million
  • Six Months Ended June 30, 2025: $120.3 million
  • Six Months Ended June 30, 2024: $114.7 million

General and Administrative Expenses

  • Three Months Ended June 30, 2025: $48.5 million
  • Three Months Ended June 30, 2024: $44.4 million
  • Six Months Ended June 30, 2025: $99.2 million
  • Six Months Ended June 30, 2024: $89.0 million

Segment Net (Loss) Income

  • Three Months Ended June 30, 2025: -$32.4 million
  • Three Months Ended June 30, 2024: $2.4 million
  • Six Months Ended June 30, 2025: -$51.8 million
  • Six Months Ended June 30, 2024: -$24.2 million

Cash Flow

Operating Cash Flow

  • Six Months Ended June 30, 2025: -$10.9 million
  • Six Months Ended June 30, 2024: $79.7 million

Investing Cash Flow

  • Six Months Ended June 30, 2025: $44.5 million
  • Six Months Ended June 30, 2024: $14.1 million

Financing Cash Flow

  • Six Months Ended June 30, 2025: -$39.5 million
  • Six Months Ended June 30, 2024: -$6.6 million

Future Outlook and Strategy

Core Business Focus

Clover Health Investments, Corp. aims to empower physicians with technology to manage chronic diseases earlier, focusing on improving care for Medicare beneficiaries through its Clover Assistant platform. The company plans to expand its reach and improve clinical decision-making through data-driven insights, with a focus on maintaining low out-of-pocket costs for members and expanding its network of providers.

Non-Core Business

The company launched Counterpart Health, Inc., a SaaS and Tech Enabled Services Solution, to extend its technology to Medicare Advantage payors and providers, aiming to enhance patient outcomes and reduce healthcare costs. This initiative is expected to provide new growth opportunities with low startup costs.

Source: LB filings The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.